Speaker illustration

Doctor Ewa Kwiecien

John Paul II Hospital, Krakow (Poland)

Evolution of left ventricular function after Wharton's jelly mesenchymal stem cells transcoronary administration: 5-year follow up in a pilot cohort of CIRCULATE-AMI Randomized Trial

Event: ESC Congress 2020

Topic: Treatment

Session: Acute Coronary Syndromes ePosters


Insights into left ventricular remodelling and clinical outcomes after Wharton's jelly multipotent stem cells transcoronary administration in a pilot cohort of CIRCULATE-AMI Trial (NCT03404063)

Event: ESC Congress 2019

Topic: Revascularisation

Session: Acute coronary syndrome treatment


Myocardial regeneration strategy using wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of circulate-acute myocardial infarction trial.

Event: ESC Congress 2018

Topic: Treatment, Other

Session: Pharmacologic treatment of acute coronary syndromes


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb